NTI receives SBIR grant funding from the NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to develop an innovative test for early diagnosis of Systemic Lupus Erythematosus (SLE), an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue, implementing a panel of microRNA and autoantibody biomarkers and overcoming limitations of current SLE testing.